Month: May 2011

News on iPS cells from some top scientists at ASGCT meeting today

There were three talks today on iPS cells here at the American Society for Gene and Cell Therapy in Seattle. Dr. James Ellis made the interesting case that it may actually be preferable to make iPS cells using genetic methods (while everyone else seems to be saying that non-genetic methods will be better). Dr. Ellis …

News on iPS cells from some top scientists at ASGCT meeting today Read More »

A crazy week for stem cells: what the heck does it all mean?

This past week was a wacky and wild one for the stem cell field. All kinds of crazy things happened all in one week. What does it all mean? Stem cells the new steroids for sports? Reports surface this week that NY Yankees pitcher Bartolo Colon, had received a non-FDA approved stem cell treatment for …

A crazy week for stem cells: what the heck does it all mean? Read More »

Make a mega-minute for spinal cord injury research

Not all minutes of our lives are created equal. The minute (many minutes) I spent as a kid in the basement of our house watching Gilligan’s Island…hmm, not much impact there. But some minutes can potentially have a mega impact. I call these mega-minutes. A seemingly small, even momentary act can have years of impact. …

Make a mega-minute for spinal cord injury research Read More »

Cancer stem cells and iPS cells

cancer stem cells

Yesterday I ran a cancer stem cells meeting here at UC Davis School of Medicine. We had some great speakers and over 150 participants including our outstanding keynote speaker, Dr. Jeremy Rich, Director of Stem Cell Research at the Cleveland Clinic. One of the ideas percolating through the meeting was that during cancer development, there …

Cancer stem cells and iPS cells Read More »

Why invest in stem cells? Progress, Patients, and Patents

Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of patients. But there is another …

Why invest in stem cells? Progress, Patients, and Patents Read More »